NVS

NYSE · Healthcare

Novartis AG

Q: What is NVS's stock price today?

NVS last closed at $146.03, down 1.46% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $81.10 and a high of $131.00. The current price represents 100% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What do Wall Street analysts say about NVS?

Among 34 analysts covering NVS, the consensus rating is Hold — 16 rate it a buy, 14 hold, and 4 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: Is Novartis AG profitable?

Novartis AG generated $41.39B in revenue during fiscal year 2026, with $10.28B reaching the bottom line as net income. The net profit margin of 24.8% is strong by most industry standards.

Q: What is NVS's P/E ratio?

NVS trades at a P/E ratio of 20.02 on trailing earnings of $7.16 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Mega-Cap Stocks Blue Chip Stocks Best Dividend Stocks Highest Dividend Yield

$146.03

-2.16 (-1.46%)

As of Mar 22, 11:07 PM ET ·

Day Range $145.30 — $148.90

52W Range $81.10 — $131.00

Open$148.77

Previous Close$148.19

Day High$148.90

Day Low$145.30

52W High$131.00

52W Low$81.10

Volume—

Avg Volume3.86M

Market Cap222.45B

P/E Ratio20.02

EPS$7.16

SectorHealthcare

Analyst Ratings

Hold

34 analysts

16 Buy 14 Hold 4 Sell

Key Financials

	FY 2026	FY 2025
Revenue	41.39B	37.94B
Net Income	10.28B	8.48B
Profit Margin	24.8%	23.6%
EBITDA	13.12B	11.42B
Free Cash Flow	—	—
Rev Growth	+9.1%	+9.1%
Debt/Equity	0.77	0.77

Dividend

Dividend Yield3.17%

Annual Dividend$4.02

Payout Ratio55.9%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Healthcare Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
AZN	AstraZeneca PLC	$183.60	-2.82%	28.6	218.85B
RHHBY	Roche Holding AG	$47.39	-2.12%	20.0	257.69B
SNY	Sanofi	$44.60	-1.63%	7.5	94.09B
GSK	GSK plc	$52.97	+1.89%	13.7	78.27B
NVO	Novo Nordisk A/S	$38.58	+1.63%	10.3	1.06T

NVS Frequently Asked Questions

What is NVS's stock price today?

NVS last closed at $146.03, down 1.46% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $81.10 and a high of $131.00. The current price represents 100% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What do Wall Street analysts say about NVS?

Among 34 analysts covering NVS, the consensus rating is Hold — 16 rate it a buy, 14 hold, and 4 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Is Novartis AG profitable?

Novartis AG generated $41.39B in revenue during fiscal year 2026, with $10.28B reaching the bottom line as net income. The net profit margin of 24.8% is strong by most industry standards.

What is NVS's P/E ratio?

NVS trades at a P/E ratio of 20.02 on trailing earnings of $7.16 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.